Pilot trial of ondansetron in the treatment of 8 patients with obsessive-compulsive disorder

Keyphrases

• Obsessive-compulsive Disorder 100%
• Ondansetron 100%
• Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) 80%
• 5-HT3 Receptor Antagonist 40%
• Clinically Significant 20%
• Risk Assessment 20%
• Monotherapy 20%
• Open-label Trial 20%
• Neuronal Network 20%
• Fixed-dose Combination 20%
• Serotonin 5-HT 20%
• Risk Perception 20%
• Compulsion 20%
• Medication-free 20%
• DSM-IV Diagnoses 20%
• Obsessive-compulsive Disorder Symptoms 20%
• Anxiolytic 20%
• Animal Models of Anxiety 20%

Neuroscience

• Obsessive-Compulsive Disorder 100%
• Ondansetron 100%
• 5-HT3 Antagonist 50%
• Serotonin 25%
• Treatment of Obsessive-Compulsive Disorder 25%
• Obsessive-Compulsive Disorder Symptoms 25%
• Compulsive Behavior 25%
• Open-Label Trial 25%
• Anxiolytic 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Zofran 100%
• Obsessive Compulsive Disorder 100%
• Symptom 50%
• Serotonin 3 Antagonist 33%
• Open-Label Trial 16%
• DSM-IV 16%
• Anxiolytic 16%
• Serotonin 16%
• Monotherapy 16%